Ad
related to: merck
Search results
Dow Jones Drops Ahead Of Jobs Data; GameStop Dives After 21% Surge
Investor's Business Daily· 28 minutes agoStock Market Today: Best Stocks To Watch Birkenstock, Netflix, Robinhood Markets and TJX — plus Dow...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga via Yahoo Finance· 22 hours agoMonday, Moderna Inc (NASDAQ:MRNA) and Merck & Co Inc (NYSE:MRK) announced the first presentation of...
Merck KGaA (MKGAF) Upgraded to Buy: Here's What You Should Know
Zacks via Yahoo Finance· 6 days agoMerck KGaA (MKGAF) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 1 day agoModerna and Merck released more positive three-year data Monday on their experimental vaccine, given...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 23 hours agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
Medical Stock Soars On Takeover; But Merck Unmoved On $3 Billion Get
Investor's Business Daily· 6 days agoSurmodics, which makes components for medical devices and tests, agreed to a $627 million takeover...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 1 day agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
Merck (MRK) to Buy Private Ophthalmology Company EyeBio
Zacks via Yahoo Finance· 5 days agoMerck's (MRK) acquisition of EyeBio is set to add the latter's lead pipeline candidate, Restoret, a...
Moderna and MSD share encouraging three-year data from trial of melanoma therapy
Clinical Trials Arena via Yahoo Finance· 6 hours agoPharmaceutical companies Moderna and Merck & Co (MSD) have announced positive results from the Phase...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 1 day agoThe company presented the latest results from its trial involving 157 people with advanced skin cancer at the annual meeting of the American Society of...
